Not yet registered on PMX
This profile is generated from public regulatory records. The company has not registered on PMX yet, and PMX has not verified it.
- Country
- United Arab Emirates
- Region
- Asia
Regulatory licences
Registered products
161 products
MISARVEN A 40/5 mgAmlodipine besylate Ph.Eur 6.94 mg, equivalent 5 mg of Amlodipine , Telmisartan Ph.Eur.40 mg/5 mg/TabletMISARVEN A 80/10 mgAmlodipine besylate Ph.Eur 13.88mg equivalent Amlodipine 10 mg , Telmisartan Ph.Eur.80 mg/10 mg/TabletMISARVEN A 80/5 mgAmlodipine besylate Ph.Eur 6.94 mg equivalent Amlodipine 5 mg , Telmisartan Ph.Eur.80 mg/5 mg/TabletMISARVEN H 40/12.5Hydrochlorothiazide USP , Telmisartan USP40 mg/12.5 mg/TabletMISARVEN H 80/12.5Hydrochlorothiazide USP , Telmisartan USP80 mg/12.5 mg/TabletNOTHROMBI 15Rivaroxaban Ph. Eur.15 mg/TabletNOTHROMBI 20Rivaroxaban Ph. Eur.20 mg/TabletNOVIRAL® 200 mgAcyclovir (208 mg including 4 % extra)200 mg/TabletNOVIRAL® 800 mgAcyclovir (832 mg including 4 % extra)800 mg/TabletOBREXA 10/160Amlodipine besylate 14 mg is equivalent to Amlodipine 10mg, Valsartan 161.85 mg equivalent to Valsartan 160 mg10mg/160mg / tabletOBREXA 5/160Amlodipine Besylate 7 mg equivalent to Amlodipine 5 mg, Valsartan 161.85 mg equivalent to Valsartan 160 mg.160mg/5mg / TabletORIZINELLevocetirizine dihydrochloride USP5 mg/1Tablet